CPP
LABU icon

Crow Point Partners’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Crow Point Partners’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-50
Closed -$84K – 274
2017
Q3 		$84K Buy
+50
New +$69.4K 0.01% 189

Other funds holding LABU

HJMC
Hellman Jordan Management Company Quincy, Massachusetts $58.9M AUM 18.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
EWA
Exencial Wealth Advisors Oklahoma City, Oklahoma $3.22B AUM 20.17% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
TCM
Traynor Capital Management Malvern, Pennsylvania $1.7B AUM 39.15% 1-Year Est. Return

Crow Point Partners's LABU Position: Q4 2017 in Review

Crow Point Partners sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q4 2017, closing a stake of 50 shares — an estimated $84K sold.

Crow Point Partners first reported a position in LABU in Q3 2017 and held it in 1 quarter. The position peaked at $84K in Q3 2017. 19 funds tracked by Wall St. Rank hold LABU as of Q4 2017.

  • Crow Point Partners reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q4 2017 after selling out during the quarter.
  • Crow Point Partners sold 50 Direxion Daily S&P Biotech Bull 3X ETF shares in Q4 2017, an estimated $84K.
  • Crow Point Partners first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q3 2017 and held it in 1 quarter.
  • Crow Point Partners's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $84K in Q3 2017.
  • 19 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q4 2017.

Based on Crow Point Partners's 13F filing for Q4 2017, filed 10 Jan 2018.